EW Edwards Lifesciences Corporation
Healthcare
Price
$93.39
Intrinsic value
$28.55
Buy price
$22.84
Discount
-227.2%
DCF walkthrough
Near-term growth (g1)10.77%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $1,358,600,000.00
- Total debt
- $704,400,000.00
- Cash & STI
- $4,252,699,904.00
- Shares out.
- 577,600,000
Overvalued
Intrinsic value$28.55
Buy price (with MOS)$22.84
Current price$93.39
Discount to intrinsic value-227.2%
7-step quality scorecard
ROE quality
HIGH_CONSISTENT- Average ROE
- 24.9%
- Current ROE
- 10.4%
- Minimum ROE
- 10.4%
Debt quality
CONSERVATIVE- Debt / Equity
- 0.07x
Moat proxy
MODERATE_PROXYCash-flow reliability
OK- Operating CF / Net income
- 1.39x
Technical chart
Confluence: NONE (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- revenueCAGR
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 5.4%
- Public economic interest
- 100.0%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.